ArticleMalaria journal2017
Maximizing the impact of malaria funding through allocative efficiency: using the right interventions in the right locations.
Article in Malaria journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 49 citations in OpenAlex.
- Models for malaria control optimization-a systematic review.Malaria journal · 2024Pooled it
- Agent-based models of malaria transmission: a systematic review.Malaria journal · 2018Pooled it
- Associations between precipitation, temperature, and malaria prevalence in children under 5 in Mali.PloS one · 2026Article
- Subnational malaria burden in Sindh, Pakistan: over a decade of evidence for tailored strategies.Malaria journal · 2025Article
- Who pays to treat malaria and how much? Analysis of the cost of illness, equity and economic burden of malaria in Uganda.Health policy and planning · 2025Article
- Examining malaria treatment and prevention spending efficiency in malaria-endemic countries, 2000-2020.Malaria journal · 2024Article
- Examining geographical inequalities for malaria outcomes and spending on malaria in 40 malaria-endemic countries, 2010-2020.Malaria journal · 2024Article
- Examining Public Sector Availability and Supply Chain Management Practices for Malaria Commodities: Findings From Northern Nigeria.Global health, science and practice · 2024Article
- Fidelity of implementation of national guidelines on malaria diagnosis for children under-five years in Rivers State, Nigeria.Malaria journal · 2024Article
- Sub-national tailoring of malaria interventions in Mainland Tanzania: simulation of the impact of strata-specific intervention combinations using modelling.Malaria journal · 2022Article
- Addressing child health inequity through case management of under-five malaria in Nigeria: an extended cost-effectiveness analysis.Malaria journal · 2022Article
- Optima TB: A tool to help optimally allocate tuberculosis spending.PLoS computational biology · 2021Article
- Time-Varying Effects of Meteorological Variables on Malaria Epidemiology in the Context of Interrupted Control Efforts in the Amazon Rainforest, 2000-2017.Frontiers in medicine · 2021Article
- How useful are malaria risk maps at the country level? Perceptions of decision-makers in Kenya, Malawi and the Democratic Republic of Congo.Malaria journal · 2020Article
- Applied mathematical modelling to inform national malaria policies, strategies and operations in Tanzania.Malaria journal · 2020Article
- Simulating the council-specific impact of anti-malaria interventions: A tool to support malaria strategic planning in Tanzania.PloS one · 2020Article
- Optimal allocation of HIV resources among geographical regions.BMC public health · 2019Article
- Beyond mapping: a case for geospatial analytics in humanitarian health.Conflict and health · 2019Article
- Optima Nutrition: an allocative efficiency tool to reduce childhood stunting by better targeting of nutrition-related interventions.BMC public health · 2018Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe high burden of malaria and limited funding means there is a necessity to maximize the allocative efficiency of malaria control programmes. Quantitative tools are urgently needed to guide budget allocation decisions.
methodsA geospatial epidemic model was coupled with costing data and an optimization algorithm to estimate the optimal allocation of budgeted and projected funds across all malaria intervention approaches. Interventions included long-lasting insecticide-treated nets (LLINs), indoor residual spraying (IRS), intermittent presumptive treatment during pregnancy (IPTp), seasonal mass chemoprevention in children (SMC), larval source management (LSM), mass drug administration (MDA), and behavioural change communication (BCC). The model was applied to six geopolitical regions of Nigeria in isolation and also the nation as a whole to minimize incidence and malaria-attributable mortality.
resultsAllocative efficiency gains could avert approximately 84,000 deaths or 15.7 million cases of malaria in Nigeria over 5 years. With an additional US$300 million available, approximately 134,000 deaths or 37.3 million cases of malaria could be prevented over 5 years. Priority funding should go to LLINs, IPTp and BCC programmes, and SMC should be expanded in seasonal areas. To minimize mortality, treatment expansion is critical and prioritized over some LLIN funding, while to minimize incidence, LLIN funding remained a priority. For areas with lower rainfall, LSM is prioritized over IRS but MDA is not recommended unless all other programmes are established.
conclusionsSubstantial reductions in malaria morbidity and mortality can be made by optimal targeting of investments to the right malaria interventions in the right areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.